Drug intelligence / Profile preview

spironolactone + beta-blockers

Development stage
Unknown
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral
01

Overview

Spironolactone + beta-blockers is a combination therapy used primarily for heart failure and hypertension. This combination leverages complementary mechanisms of action: spironolactone is a potassium-sparing diuretic that acts as an aldosterone antagonist, while beta-blockers reduce the effects of stress hormones on the heart and blood vessels. The combination has shown additive effects on cardiac remodeling in heart failure patients, though hemodynamic improvements may not be greater than with either drug alone. Beta-blockers can blunt the increase in plasma renin levels induced by diuretics, while diuretics can decrease the sodium and water retention caused by beta-blockers.

02

Targets

MR (Mineralocorticoid receptor)ADRB1 (β1)ADRB2 (β2)

Beyond the preview

Go deeper on spironolactone + beta-blockers.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on spironolactone + beta-blockers.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call